RecruitingNCT07742878

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Sponsor

Rebiscan, Inc.

Enrollment

10 participants

Start Date

Jul 14, 2026

Study Type

OBSERVATIONAL

Conditions

Mild Traumatic Brain Injury, Concussion Binocular Visual Function Neuro-Ophthalmology Saccadic Eye Movements

Summary

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

Eligibility

Min Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Binocular ophthalmic neurodiagnostic device for people with binocular visual function, mild traumatic brain injury, concussion, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBinocular ophthalmic neurodiagnostic device

Participants will undergo non-invasive binocular ophthalmic neurodiagnostic measurements and ocular assessments. No treatment or intervention will be administered as part of the study.